Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma

Long-term kinetics of antibody (Ab) and cell-mediated immune (CMI) response to full anti-SARS-CoV-2 vaccine schedule and booster doses in Multiple Myeloma (MM) patients remain unclear. We prospectively evaluated Ab and CMI response to mRNA vaccines in 103 SARS-CoV-2-naïve MM patients (median age 66,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancuso, Katia, Zamagni, Elena, Solli, Vincenza, Gabrielli, Liliana, Leone, Marta, Pantani, Lucia, Rocchi, Serena, Rizzello, Ilaria, Tacchetti, Paola, Ghibellini, Stefano, Favero, Emanuele, Ursi, Margherita, Talarico, Marco, Barbato, Simona, Kanapari, Ajsi, Bigi, Flavia, Puppi, Michele, Terragna, Carolina, Borsi, Enrica, Martello, Marina, Poletti, Andrea, Scatà, Alessandra, Nepoti, Giuliana, Ruffini, Barbara, Lazzarotto, Tiziana, Cavo, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249866/
https://www.ncbi.nlm.nih.gov/pubmed/37305577
http://dx.doi.org/10.3389/fonc.2023.1208741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249866/
https://www.ncbi.nlm.nih.gov/pubmed/37305577
http://dx.doi.org/10.3389/fonc.2023.1208741

Ejemplares similares